annual SGA:
$177.74M+$44.03M(+32.93%)Summary
- As of today (July 1, 2025), CPRX annual SGA is $177.74 million, with the most recent change of +$44.03 million (+32.93%) on December 31, 2024.
- During the last 3 years, CPRX annual SGA has risen by +$128.11 million (+258.14%).
- CPRX annual SGA is now at all-time high.
Performance
CPRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$46.91M+$2.72M(+6.15%)Summary
- As of today (July 1, 2025), CPRX quarterly SGA is $46.91 million, with the most recent change of +$2.72 million (+6.15%) on March 31, 2025.
- Over the past year, CPRX quarterly SGA has dropped by -$27.00 thousand (-0.06%).
- CPRX quarterly SGA is now -0.06% below its all-time high of $46.94 million, reached on March 31, 2024.
Performance
CPRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$1.04B+$197.35M(+23.38%)Summary
- As of today (July 1, 2025), CPRX TTM SGA is $1.04 billion, with the most recent change of +$197.35 million (+23.38%) on March 31, 2025.
- Over the past year, CPRX TTM SGA has increased by +$890.70 million (+590.14%).
- CPRX TTM SGA is now at all-time high.
Performance
CPRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CPRX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.9% | -0.1% | +590.1% |
| 3 y3 years | +258.1% | +185.5% | +1852.7% |
| 5 y5 years | +381.9% | +366.2% | +2480.0% |
CPRX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +258.1% | -0.1% | +263.1% | at high | +1530.2% |
| 5 y | 5-year | at high | +381.9% | -0.1% | +369.8% | at high | +311.7% |
| alltime | all time | at high | >+9999.0% | -0.1% | >+9999.0% | at high | +268.5% |
CPRX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $46.91M(+6.2%) | $177.71M(-0.0%) |
| Dec 2024 | $177.74M(+32.9%) | $44.19M(-3.7%) | $177.74M(+1.2%) |
| Sep 2024 | - | $45.88M(+12.6%) | $175.58M(+7.5%) |
| Jun 2024 | - | $40.73M(-13.2%) | $163.26M(+8.2%) |
| Mar 2024 | - | $46.94M(+11.7%) | $150.93M(+12.9%) |
| Dec 2023 | $133.71M(+134.2%) | $42.04M(+25.3%) | $133.71M(+26.4%) |
| Sep 2023 | - | $33.56M(+18.2%) | $105.76M(+23.2%) |
| Jun 2023 | - | $28.40M(-4.4%) | $85.85M(+22.0%) |
| Mar 2023 | - | $29.72M(+110.9%) | $70.37M(+23.3%) |
| Dec 2022 | $57.09M(+15.0%) | $14.09M(+3.2%) | $57.09M(+1.5%) |
| Sep 2022 | - | $13.65M(+5.7%) | $56.22M(+2.7%) |
| Jun 2022 | - | $12.92M(-21.4%) | $54.73M(+2.6%) |
| Mar 2022 | - | $16.43M(+24.2%) | $53.34M(+7.5%) |
| Dec 2021 | $49.63M(+12.2%) | $13.23M(+8.8%) | $49.63M(-0.3%) |
| Sep 2021 | - | $12.15M(+5.4%) | $49.75M(+4.6%) |
| Jun 2021 | - | $11.53M(-9.3%) | $47.59M(+1.5%) |
| Mar 2021 | - | $12.72M(-4.8%) | $46.89M(+6.0%) |
| Dec 2020 | $44.23M(+19.9%) | $13.35M(+33.7%) | $44.23M(+4.6%) |
| Sep 2020 | - | $9.98M(-7.8%) | $42.29M(+4.7%) |
| Jun 2020 | - | $10.83M(+7.7%) | $40.37M(+4.8%) |
| Mar 2020 | - | $10.06M(-11.8%) | $38.53M(+4.5%) |
| Dec 2019 | $36.88M(+132.3%) | $11.41M(+41.4%) | $36.88M(+13.8%) |
| Sep 2019 | - | $8.07M(-10.2%) | $32.40M(+15.8%) |
| Jun 2019 | - | $8.99M(+6.8%) | $27.97M(+29.4%) |
| Mar 2019 | - | $8.42M(+21.5%) | $21.62M(+36.2%) |
| Dec 2018 | $15.88M(+117.3%) | $6.93M(+90.1%) | $15.88M(+43.6%) |
| Sep 2018 | - | $3.64M(+38.5%) | $11.06M(+22.7%) |
| Jun 2018 | - | $2.63M(-1.6%) | $9.01M(+11.1%) |
| Mar 2018 | - | $2.67M(+26.9%) | $8.11M(+11.1%) |
| Dec 2017 | $7.30M(-7.7%) | $2.11M(+31.6%) | $7.30M(+9.2%) |
| Sep 2017 | - | $1.60M(-7.4%) | $6.69M(+2.8%) |
| Jun 2017 | - | $1.73M(-7.3%) | $6.51M(-8.1%) |
| Mar 2017 | - | $1.87M(+24.9%) | $7.08M(-10.4%) |
| Dec 2016 | $7.91M(-8.0%) | $1.49M(+5.2%) | $7.91M(-9.9%) |
| Sep 2016 | - | $1.42M(-38.4%) | $8.78M(-5.9%) |
| Jun 2016 | - | $2.31M(-14.3%) | $9.33M(-0.2%) |
| Mar 2016 | - | $2.69M(+14.0%) | $9.35M(+8.7%) |
| Dec 2015 | $8.60M | $2.36M(+19.5%) | $8.60M(+9.7%) |
| Sep 2015 | - | $1.97M(-14.9%) | $7.84M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | $2.32M(+19.4%) | $7.08M(+25.3%) |
| Mar 2015 | - | $1.94M(+21.4%) | $5.66M(+26.4%) |
| Dec 2014 | $4.47M(+102.0%) | $1.60M(+30.8%) | $4.47M(+27.4%) |
| Sep 2014 | - | $1.22M(+37.2%) | $3.51M(+28.6%) |
| Jun 2014 | - | $891.20K(+17.3%) | $2.73M(+15.7%) |
| Mar 2014 | - | $759.70K(+18.9%) | $2.36M(+6.6%) |
| Dec 2013 | $2.21M(-13.5%) | $638.80K(+44.7%) | $2.21M(-5.2%) |
| Sep 2013 | - | $441.40K(-15.4%) | $2.34M(-7.4%) |
| Jun 2013 | - | $521.50K(-14.9%) | $2.52M(-0.5%) |
| Mar 2013 | - | $613.10K(-19.4%) | $2.54M(-0.9%) |
| Dec 2012 | $2.56M(-5.1%) | $760.70K(+21.0%) | $2.56M(-10.9%) |
| Sep 2012 | - | $628.90K(+17.6%) | $2.88M(+4.1%) |
| Jun 2012 | - | $534.60K(-16.1%) | $2.76M(+1.6%) |
| Mar 2012 | - | $637.40K(-40.7%) | $2.72M(+0.8%) |
| Dec 2011 | $2.70M(+22.3%) | $1.07M(+107.8%) | $2.70M(+18.6%) |
| Sep 2011 | - | $516.90K(+5.1%) | $2.28M(+5.0%) |
| Jun 2011 | - | $491.80K(-20.1%) | $2.17M(-2.0%) |
| Mar 2011 | - | $615.30K(-5.6%) | $2.21M(+0.2%) |
| Dec 2010 | $2.21M(+1.3%) | $652.00K(+59.6%) | $2.21M(+1.4%) |
| Sep 2010 | - | $408.40K(-23.7%) | $2.18M(-1.5%) |
| Jun 2010 | - | $535.20K(-12.4%) | $2.21M(+0.2%) |
| Mar 2010 | - | $610.80K(-1.8%) | $2.20M(+1.2%) |
| Dec 2009 | $2.18M(-0.3%) | $622.20K(+41.0%) | $2.18M(+5.0%) |
| Sep 2009 | - | $441.30K(-16.8%) | $2.07M(-1.0%) |
| Jun 2009 | - | $530.60K(-9.1%) | $2.10M(-1.5%) |
| Mar 2009 | - | $583.90K(+12.5%) | $2.13M(-2.6%) |
| Dec 2008 | $2.18M(+7.2%) | $519.10K(+12.1%) | $2.18M(+4.7%) |
| Sep 2008 | - | $463.20K(-17.5%) | $2.08M(+0.8%) |
| Jun 2008 | - | $561.50K(-12.2%) | $2.07M(+6.6%) |
| Mar 2008 | - | $639.70K(+52.1%) | $1.94M(-4.7%) |
| Dec 2007 | $2.04M(+6.4%) | $420.60K(-5.9%) | $2.04M(-6.6%) |
| Sep 2007 | - | $447.10K(+3.0%) | $2.18M(-23.2%) |
| Jun 2007 | - | $434.20K(-40.9%) | $2.84M(+13.9%) |
| Mar 2007 | - | $734.60K(+30.2%) | $2.49M(+41.8%) |
| Dec 2006 | $1.91M(+289.1%) | $564.20K(-49.0%) | $1.76M(+47.3%) |
| Sep 2006 | - | $1.11M(+1175.1%) | $1.19M(+1275.1%) |
| Jun 2006 | - | $86.80K | $86.80K |
| Dec 2005 | $491.70K(+198.5%) | - | - |
| Dec 2004 | $164.70K | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual SGA year-on-year change?
- What is Catalyst Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly SGA year-on-year change?
- What is Catalyst Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM SGA year-on-year change?
What is Catalyst Pharmaceuticals annual SGA?
The current annual SGA of CPRX is $177.74M
What is the all time high annual SGA for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual SGA is $177.74M
What is Catalyst Pharmaceuticals annual SGA year-on-year change?
Over the past year, CPRX annual SGA has changed by +$44.03M (+32.93%)
What is Catalyst Pharmaceuticals quarterly SGA?
The current quarterly SGA of CPRX is $46.91M
What is the all time high quarterly SGA for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly SGA is $46.94M
What is Catalyst Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, CPRX quarterly SGA has changed by -$27.00K (-0.06%)
What is Catalyst Pharmaceuticals TTM SGA?
The current TTM SGA of CPRX is $1.04B
What is the all time high TTM SGA for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM SGA is $1.04B
What is Catalyst Pharmaceuticals TTM SGA year-on-year change?
Over the past year, CPRX TTM SGA has changed by +$890.70M (+590.14%)